GJB2 Gene Keratitis Ichthyosis Deafness Syndrome Autosomal Dominant Genetic Test
Are you concerned about the possibility of Keratitis-Ichthyosis-Deafness (KID) syndrome in your family? DNA Labs UAE offers a comprehensive genetic test that can provide valuable insights into this rare autosomal dominant disorder.
Test Name: GJB2 Gene Keratitis Ichthyosis Deafness Syndrome Autosomal Dominant Genetic Test
Components
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Ear Nose Throat Disorders
- Doctor: ENT Doctor
- Test Department: Genetics
- Pre Test Information: Clinical History of Patient who is going for SLC52A3 Gene Brown-Vialetto-Van Laere syndrome 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SLC52A3 Gene Brown-Vialetto-Van Laere syndrome 1 NGS Genetic DNA Test gene SLC52A16
Test Details
The GJB2 gene is associated with several genetic disorders, including Keratitis-Ichthyosis-Deafness (KID) syndrome. KID syndrome is a rare autosomal dominant disorder characterized by a combination of symptoms such as keratitis (inflammation of the cornea), ichthyosis (a skin disorder causing dry, scaly skin), and deafness.
NGS (Next-Generation Sequencing) genetic testing is a high-throughput method used to analyze multiple genes simultaneously. It allows for the identification of genetic variations or mutations in the GJB2 gene and other genes associated with various genetic disorders. NGS testing can help in the diagnosis of KID syndrome by identifying specific mutations in the GJB2 gene.
The autosomal dominant inheritance pattern means that an affected individual has a 50% chance of passing the mutated gene to their offspring. Genetic testing can be useful in identifying individuals at risk of inheriting the disorder and providing appropriate genetic counseling and management.
It is important to note that the interpretation of NGS results should always be done by a qualified healthcare professional or genetic counselor who can provide accurate diagnosis, counseling, and guidance regarding treatment options and management strategies.
| Test Name | GJB2 Gene Keratitis ichthyosis deafness syndrome autosomal dominant Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Ear Nose Throat Disorders |
| Doctor | ENT Doctor |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for SLC52A3 Gene Brown-Vialetto-Van Laere syndrome 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SLC52A3 Gene Brown-Vialetto-Van Laere syndrome 1 NGS Genetic DNA Test gene SLC52A16 |
| Test Details |
The GJB2 gene is associated with several genetic disorders, including Keratitis-Ichthyosis-Deafness (KID) syndrome. KID syndrome is a rare autosomal dominant disorder characterized by a combination of symptoms such as keratitis (inflammation of the cornea), ichthyosis (a skin disorder causing dry, scaly skin), and deafness. NGS (Next-Generation Sequencing) genetic testing is a high-throughput method used to analyze multiple genes simultaneously. It allows for the identification of genetic variations or mutations in the GJB2 gene and other genes associated with various genetic disorders. NGS testing can help in the diagnosis of KID syndrome by identifying specific mutations in the GJB2 gene. The autosomal dominant inheritance pattern means that an affected individual has a 50% chance of passing the mutated gene to their offspring. Genetic testing can be useful in identifying individuals at risk of inheriting the disorder and providing appropriate genetic counseling and management. It is important to note that the interpretation of NGS results should always be done by a qualified healthcare professional or genetic counselor who can provide accurate diagnosis, counseling, and guidance regarding treatment options and management strategies. |
